DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0006413 | Burkitt Lymphoma | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0027439 | Nasopharyngeal Neoplasms | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0014170 | Endometrial Neoplasms | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0239946 | Fibrosis, Liver | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0205698 | Undifferentiated carcinoma | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0042345 | Varicosity | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0035222 | Respiratory Distress Syndrome, Adult | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0011616 | Contact Dermatitis | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0030297 | Pancreatic Neoplasm | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0007102 | Malignant tumor of colon | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0033860 | Psoriasis | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0279628 | Adenocarcinoma Of Esophagus | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0037274 | Dermatologic disorders | AKR1B10 | 57016 | aldo-keto reductase family 1 member B10 | O60218 |
C0025958 | Microcephaly | PARP11 | 57097 | poly(ADP-ribose) polymerase family member 11 | Q9NR21 |
C0042769 | Virus Diseases | PARP11 | 57097 | poly(ADP-ribose) polymerase family member 11 | Q9NR21 |
C0524851 | Neurodegenerative Disorders | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0678222 | Breast Carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0079773 | Lymphoma, T-Cell, Cutaneous | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C1332979 | Childhood Lymphoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C2931822 | Nasopharyngeal carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0009402 | Colorectal Carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0006826 | Malignant Neoplasms | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0036341 | Schizophrenia | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0017636 | Glioblastoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024